Subject: RE: CoE in Viral Hepatitis Elimination Georgia_Editorial_ 7 June 2019 FA clean
From: "Averhoff, Francisco (CDC/DDID/NCHHSTP/DVH)" <[email-masked]>
To: Jeffrey Lazarus <[email-masked]>
Cc: "Gamkrelidze, Amiran (CDC ncdc.ge)" <[email-masked]>, "Davit Sergeenko ([email-masked])" <[email-masked]>, Massimo Colombo <[email-masked]>, Stefano Gnes <[email-masked]>, "Nasrullah, Muazzam (CDC/DDID/NCHHSTP/DVH)" <[email-masked]>, Tamar Gabunia <[email-masked]>
Date: Fri, 07 Jun 2019 18:49:00 +0000

Dear Jeff, thank you for very nice suggestion, I shall do so!
J

Francisco Averhoff MD, MPH

CAPT US Public Health Service

Associate Director for Global Health

Division of Viral Hepatitis

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Centers for Disease Control and Prevention

1600 Clifton Road, MS G-37

Atlanta, GA 30333

phone: 404-718-8501

fax: 404-718-8588

e-mail:
[email-masked]

From: Jeffrey Lazarus <[email-masked]>

Sent: Friday, June 7, 2019 2:21 PM

To: Averhoff, Francisco (CDC/DDID/NCHHSTP/DVH) <[email-masked]>

Cc: Gamkrelidze, Amiran (CDC ncdc.ge) <[email-masked]>; Davit Sergeenko ([email-masked]) <[email-masked]>; Massimo Colombo <[email-masked]>; Stefano Gnes <[email-masked]>; Nasrullah, Muazzam (CDC/DDID/NCHHSTP/DVH) <[email-masked]>;
Tamar Gabunia <[email-masked]>

Subject: Re: CoE in Viral Hepatitis Elimination Georgia_Editorial_ 7 June 2019 FA clean

Here you go. What happened to asking Margaret? I think you should as a TAG member.

I, Jeffrey Lazarus____, approve submission of the manuscript  “Excellence in Viral Hepatitis Elimination
– Lessons from Georgia

”  into CDC  clearance.”

Jeff

---

Jeffrey V Lazarus

Associate Research Professor

ISGlobal

Barcelona Institute for Global Health

Hospital Clínic - University of Barcelona

Calle de Rossellón 132, 4º2ª

ES-08036 Barcelona, Spain

T: @JVLazarus

[email-masked]

www.isglobal.org

&

Vice-Chair EASL International Liver Foundation

Co-chair HIV Outcomes Beyond Viral Suppression coalition

El vie., 7 jun. 2019 a las 20:11, Averhoff, Francisco (CDC/DDID/NCHHSTP/DVH) (<[email-masked]>) escribió:

Dear all,

Please find attached a draft manuscript, I would appreciate your agreement to serve as co-authors following your review.  We plan to submit to
J Hepatology in time for World Hepatitis Day.  We specifically included authors from Georgia, EILF, and CDC.  I would request:

1.
Please review and offer edits/comments

2.
Please complete below approval, latest 12 June 2019

3.
Dr. Massimo, please fill in your affiliation on the cover page

I,  _______________________, approve submission of the manuscript  “Excellence in Viral Hepatitis Elimination
– Lessons from Georgia

”  into CDC  clearance.”

Special thanks to Jeff, Stefano and Muazzam for early comments/edits/suggestions.  Please let me know your thoughts/concerns.  Have a good weekend!

Best, FA

This message is intended exclusively for its addressee and may contain information that is CONFIDENTIAL and protected by professional privilege.
If you are not the intended recipient you are hereby notified that any dissemination, copy or disclosure of this communication is strictly prohibited by law. If this message has been received in error, please immediately notify us via e-mail and delete it.

DATA PROTECTION. We inform you that your personal data, including your e-mail address and data included in your email correspondence, are included
in the ISGlobal Foundation files. Your personal data will be used for the purpose of contacting you and sending information on the activities of the above foundations. You can exercise your rights of access, rectification, cancellation and opposition by contacting
the following address: [email-masked].
ISGlobal Privacy Policy at
www.isglobal.org.

-----------------------------------------------------------------------------------------------------------------------------

CONFIDENCIALIDAD. Este mensaje y sus anexos se dirigen exclusivamente a su destinatario y puede contener información confidencial, por lo que la
utilización, divulgación y/o copia sin autorización está prohibida por la legislación vigente. Si ha recibido este mensaje por error, le rogamos lo comunique inmediatamente por esta misma vía y proceda a su destrucción.

PROTECCIÓN DE DATOS. Sus datos de carácter personal utilizados en este envío, incluida su dirección de e-mail, forman parte de ficheros de titularidad
de la Fundación ISGlobal  para cualquier finalidades de contacto, relación institucional y/o envío de información sobre sus actividades. Los datos que usted nos pueda facilitar contestando este correo quedarán incorporados en los correspondientes ficheros,
autorizando el uso de su dirección de e-mail para las finalidades citadas. Puede ejercer los derechos de acceso, rectificación, cancelación y oposición dirigiéndose a
[email-masked]
.
Política de privacidad en
www.isglobal.org.